194 related articles for article (PubMed ID: 12481542)
1. Bone growth stimulators. New tools for treating bone loss and mending fractures.
Whitfield JF; Morley P; Willick GE
Vitam Horm; 2002; 65():1-80. PubMed ID: 12481542
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis.
Whitfield JF; Morley P; Willick GE
Treat Endocrinol; 2002; 1(3):175-90. PubMed ID: 15799210
[TBL] [Abstract][Full Text] [Related]
3. How to grow bone to treat osteoporosis and mend fractures.
Whitfield JF
Curr Osteoporos Rep; 2003 Jun; 1(1):32-40. PubMed ID: 16036063
[TBL] [Abstract][Full Text] [Related]
4. The parathyroid hormone, its fragments and analogues--potent bone-builders for treating osteoporosis.
Whitfield J; Morley P; Willick G
Expert Opin Investig Drugs; 2000 Jun; 9(6):1293-315. PubMed ID: 11060744
[TBL] [Abstract][Full Text] [Related]
5. How to grow bone to treat osteoporosis and mend fractures.
Whitfield JF
Curr Rheumatol Rep; 2003 Feb; 5(1):45-56. PubMed ID: 12590885
[TBL] [Abstract][Full Text] [Related]
6. The parathyroid hormones: bone-forming agents for treatment of osteoporosis.
Whitfield JF; Morley P; Willick GE
Medscape Womens Health; 2000; 5(5):E5. PubMed ID: 11113778
[TBL] [Abstract][Full Text] [Related]
7. New therapeutic targets for osteoporosis: beyond denosumab.
Lim V; Clarke BL
Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
[TBL] [Abstract][Full Text] [Related]
8. Clinical review 123: Anabolic therapy for osteoporosis.
Rosen CJ; Bilezikian JP
J Clin Endocrinol Metab; 2001 Mar; 86(3):957-64. PubMed ID: 11238469
[TBL] [Abstract][Full Text] [Related]
9. The bone-building action of the parathyroid hormone: implications for the treatment of osteoporosis.
Whitfield JF; Morley P; Willick GE
Drugs Aging; 1999 Aug; 15(2):117-29. PubMed ID: 10495071
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone: an anabolic treatment for osteoporosis.
Morley P; Whitfield JF; Willick GE
Curr Pharm Des; 2001 May; 7(8):671-87. PubMed ID: 11375775
[TBL] [Abstract][Full Text] [Related]
11. The treatment of osteoporosis. Antiresorptive therapy.
Miller PD
Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
[TBL] [Abstract][Full Text] [Related]
12. Restoring aging bones.
Rosen CJ
Sci Am; 2003 Mar; 288(3):70-7. PubMed ID: 12616861
[No Abstract] [Full Text] [Related]
13. Anti-resorptive therapies for osteoporosis.
Reid IR
Semin Cell Dev Biol; 2008 Oct; 19(5):473-8. PubMed ID: 18760372
[TBL] [Abstract][Full Text] [Related]
14. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
Kastelan D; Giljevic Z; Kraljevic I; Korsic M
Med Hypotheses; 2006; 67(5):1052-3. PubMed ID: 16790322
[TBL] [Abstract][Full Text] [Related]
15. Miscellaneous and experimental agents.
Reginster JY
Am J Med Sci; 1997 Jan; 313(1):33-40. PubMed ID: 9001164
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
17. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
18. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
[TBL] [Abstract][Full Text] [Related]
19. [A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation].
Kitao T; Ito Y; Fukui M; Yamamoto M; Shoji Y; Takeda S; Shirahase H
Yakugaku Zasshi; 2019; 139(1):19-25. PubMed ID: 30606923
[TBL] [Abstract][Full Text] [Related]
20. The control of bone growth by parathyroid hormone, leptin, & statins.
Whitfield JF; Morley P; Willick GE
Crit Rev Eukaryot Gene Expr; 2002; 12(1):23-51. PubMed ID: 12433064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
